276 related articles for article (PubMed ID: 7774641)
21. Viral DNA contamination is responsible for Epstein-Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein-Barr virus B-lymphoblastoid cell line.
Berthomé M; Gallot G; Vivien R; Clémenceau B; Nguyen JM; Coste-Burel M; Vié H
Cancer Immunol Immunother; 2010 Dec; 59(12):1867-75. PubMed ID: 20809356
[TBL] [Abstract][Full Text] [Related]
22. Transfection of single-stranded hepatitis A virus RNA activates MHC class I pathway.
Suzuki K; Yanagi M; Mori-Aoki A; Moriyama E; Ishii KJ; Kohn LD
Clin Exp Immunol; 2002 Feb; 127(2):234-42. PubMed ID: 11876745
[TBL] [Abstract][Full Text] [Related]
23. Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential.
Bewarder M; Held G; Thurner L; Stilgenbauer S; Smola S; Preuss KD; Carbon G; Bette B; Christofyllakis K; Bittenbring JT; Felbel A; Hasse A; Murawski N; Kaddu-Mulindwa D; Neumann F
Cancer Immunol Immunother; 2020 Aug; 69(8):1535-1548. PubMed ID: 32300857
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.
Chawla A; Alatrash G; Philips AV; Qiao N; Sukhumalchandra P; Kerros C; Diaconu I; Gall V; Neal S; Peters HL; Clise-Dwyer K; Molldrem JJ; Mittendorf EA
Cancer Immunol Immunother; 2016 Jun; 65(6):741-51. PubMed ID: 27129972
[TBL] [Abstract][Full Text] [Related]
25. Chronic HIV-1 Tat action induces HLA-DR downregulation in B cells: A mechanism for lymphoma immune escape in people living with HIV.
Shmakova A; Hugot C; Kozhevnikova Y; Schwager Karpukhina A; Tsimailo I; Gérard L; Boutboul D; Oksenhendler E; Szewczyk-Roszczenko O; Roszczenko P; Buzun K; Sheval EV; Germini D; Vassetzky Y
J Med Virol; 2024 Feb; 96(2):e29423. PubMed ID: 38285479
[TBL] [Abstract][Full Text] [Related]
26. Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection.
Maroui MA; Odongo GA; Mundo L; Manara F; Mure F; Fusil F; Jay A; Gheit T; Michailidis TM; Ferrara D; Leoncini L; Murray P; Manet E; Ohlmann T; De Boevre M; De Saeger S; Cosset FL; Lazzi S; Accardi R; Herceg Z; Gruffat H; Khoueiry R
Proc Natl Acad Sci U S A; 2024 Apr; 121(16):e2314426121. PubMed ID: 38574017
[TBL] [Abstract][Full Text] [Related]
27. Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain.
Xiaoling G; Ying L; Jing L; Huifang L; Xia Z; Qingqing F; Ping Z
Cancer Immunol Immunother; 2005 Nov; 54(11):1106-14. PubMed ID: 15889252
[TBL] [Abstract][Full Text] [Related]
28. Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.
Mancao C; Altmann M; Jungnickel B; Hammerschmidt W
Blood; 2005 Dec; 106(13):4339-44. PubMed ID: 16076866
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1α.
Incrocci R; Monroy Del Toro R; Devitt G; Salimian M; Braich K; Swanson-Mungerson M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612754
[TBL] [Abstract][Full Text] [Related]
30. Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation.
Fares S; Spiess K; Olesen ETB; Zuo J; Jackson S; Kledal TN; Wills MR; Rosenkilde MM
mBio; 2019 Jan; 10(1):. PubMed ID: 30647152
[TBL] [Abstract][Full Text] [Related]
31. Emergence of non-major-histocompatibility-complex-restricted lytic CD8+ cells in the blood of nasopharyngeal carcinoma patients.
Lakhdar M; Thameur H; Maalej M; Ben Ayed F; Ladgham A
Cancer Immunol Immunother; 1993 Jul; 37(2):131-9. PubMed ID: 8391392
[TBL] [Abstract][Full Text] [Related]
32. Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells.
Stroobant V; Demotte N; Luiten RM; Leonhardt RM; Cresswell P; Bonehill A; Michaux A; Ma W; Mulder A; Van den Eynde BJ; van der Bruggen P; Vigneron N
Eur J Immunol; 2012 Jun; 42(6):1417-28. PubMed ID: 22678898
[TBL] [Abstract][Full Text] [Related]
33. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common
Lim WC; Marques Da Costa ME; Godefroy K; Jacquet E; Gragert L; Rondof W; Marchais A; Nhiri N; Dalfovo D; Viard M; Labaied N; Khan AM; Dessen P; Romanel A; Pasqualini C; Schleiermacher G; Carrington M; Zitvogel L; Scoazec JY; Geoerger B; Salmon J
Front Immunol; 2023; 14():1265469. PubMed ID: 38318504
[TBL] [Abstract][Full Text] [Related]
34. Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion.
Silva AL; Omerovic J; Jardetzky TS; Longnecker R
J Virol; 2004 Jun; 78(11):5946-56. PubMed ID: 15140992
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2.
Kersten C; Delabie J; Gaudernack G; Smeland EB; Fosså A
Cancer Immunol Immunother; 2004 Dec; 53(12):1119-26. PubMed ID: 15185015
[TBL] [Abstract][Full Text] [Related]
36. T-cell responses to multiple antigens presented by RNA-transfected APCs: a possible immunomonitoring tool.
Bartido SM; Zier K
Cancer Immunol Immunother; 2004 Feb; 53(2):100-9. PubMed ID: 13680195
[TBL] [Abstract][Full Text] [Related]
37. Expression, purification and preliminary X-ray crystallographic analysis of the human major histocompatibility antigen HLA-B*1402 in complex with a viral peptide and with a self-peptide.
Kumar P; Vahedi-Faridi A; Merino E; López de Castro JA; Volz A; Ziegler A; Saenger W; Uchanska-Ziegler B
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jul; 63(Pt 7):631-4. PubMed ID: 17620730
[TBL] [Abstract][Full Text] [Related]
38. SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features.
Sureda-Gómez M; Iaccarino I; De Bolòs A; Meyer MA; Balsas P; Richter J; Rodríguez ML; López C; Carreras-Caballé M; Glaser S; Nadeu F; Jares P; Siciliano MC; Bellan C; Tornambè S; Boccacci R; Clot G; Leoncini L; Campo E; Siebert R; Amador V; Klapper W
Blood; 2024 Apr; ():. PubMed ID: 38620074
[TBL] [Abstract][Full Text] [Related]
39. Analysis and prediction of affinity of TAP binding peptides using cascade SVM.
Bhasin M; Raghava GP
Protein Sci; 2004 Mar; 13(3):596-607. PubMed ID: 14978300
[TBL] [Abstract][Full Text] [Related]
40. EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma.
Mannucci S; Luzzi A; Carugi A; Gozzetti A; Lazzi S; Malagnino V; Simmonds M; Cusi MG; Leoncini L; van den Bosch CA; De Falco G
Adv Hematol; 2012; 2012():149780. PubMed ID: 22593768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
